SCHEMBL3979459

SCHEMBL3979459

COc1ccc(Nc2ccccc2N)cc1

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.96
GAA P10253 5/20 0.96
KDM4E B2RXH2 4/20 0.96
ALDH1A1 P00352 4/20 0.96
TDP1 Q9NUW8 3/20 0.96
RAB9A P51151 3/20 0.96
MEN1 O00255 2/20 0.96
KMT2A Q03164 2/20 0.96
THRB P10828 2/20 0.96
RECQL P46063 2/20 0.96
HTT P42858 2/20 0.96
MMP14 P50281 1/20 0.96
HSD17B10 Q99714 2/20 0.63
TP53 P04637 1/20 0.63
APP P05067 1/20 0.63
HPGD P15428 1/20 0.63
ALOX15 P16050 1/20 0.63
SNCA P37840 1/20 0.63
BLM P54132 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30039228 1.00 MAPT (0.96) MAPTGAAKDM4EALDH1A1TDP1
Hydrochloric Acid SCHEMBL6438776 0.98 MAPT (1.00) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL6652801 0.88 MAPT (0.75) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL1921461 0.86 RAB9A (0.72) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL4607773 0.84 MAPT (0.86) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL27546857 0.82 MAPT (0.73) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL4924540 0.81 MAPT (0.67) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL3977426 0.81 MAPT (0.68) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL4945734 0.81 GAA (0.66) MAPTGAAKDM4EALDH1A1TDP1
SCHEMBL5832931 0.81 MAPT (0.66) MAPTGAAKDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1599964-B Electroactive polymers and devices made therefrom DOW GLOBAL TECHNOLOGIES INC 2010-05-12 CN claimed
CN-1599964-A Electroactive polymers and devices made therefrom DOW CHEMICAL CO (US) 2005-03-23 CN claimed
CN-110870089-B Organic electroluminescent blue light-emitting device 三星显示有限公司 2022-12-09 CN disclosed
CN-110915013-B Organic electroluminescent blue light-emitting device 三星显示有限公司 2022-12-02 CN disclosed
US-10730842-B2 Small molecule inhibitors of DYRK1A and uses thereof ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2020-08-04 US disclosed
US-10730842-B2 Small molecule inhibitors of DYRK1A and uses thereof ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2020-08-04 US disclosed
CN-110915013-A Organic electroluminescent blue light-emitting device 赛诺拉有限公司 2020-03-24 CN disclosed
CN-110870089-A Organic electroluminescent blue light-emitting device 赛诺拉有限公司 2020-03-06 CN disclosed
CN-107011268-B The 1,3,6,8- tetra- of bipolarity D- π-A configuration replaces pyrenyl material and preparation method and application 中国矿业大学 2019-07-23 CN disclosed
US-20190055212-A1 HISTONE DEMETHYLASE INHIBITORS GWALTNEY STEPHEN (US) 2019-02-21 US disclosed
WO-2017143011-A1 HISTONE DEMETHYLASE INHIBITORS Chrysalis, Inc. (US) 2017-08-24 WO disclosed
WO-2002028839-A1 BENZIMIDAZOLE AND INDOLE DERIVATIVES AS CRF RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2002-04-11 WO disclosed
US-4296114-A 3,4-Dihydro-3-oxopyrido[2,3-b]-pyrazines, compositions and use thereof FISONS LIMITED (GB) 1981-10-20 US disclosed
US-4224445-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC HOFFMANN-LA ROCHE INC. (US) 1980-09-23 US disclosed
EP-0008864-A1 Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them FISONS plc (GB) 1980-03-19 EP disclosed
US-4177193-A ALKOXYCARBONYL, ALKYLAMINOSULFONYL-SUBSTITUTED THIOPHENE INTERMEDIATES FOR THE 4-HYDROXY-N-SUBSTITUTED-2H-THIENO(2,3-E)-1,2-THIAZINE-3-CARBOXAMIDE-1,1 -DIOXIDES; ANTIINFLAMMATORY, ANALGESIC HOFFMAN-LA ROCHE INC. (US) 1979-12-04 US disclosed
US-4134898-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC HOFFMANN-LA ROCHE INC. (US) 1979-01-16 US disclosed
US-4076709-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1978-02-28 US disclosed
US-4009994-A Process and product of optical brightening with quaternized benzofuranyl-benzimidazoles CIBA-GEIGY CORPORATION (US) 1977-03-01 US disclosed
US-3940417-A Quaternised benzofuranyl-benzimidazoles CIBA-GEIGY CORPORATION (US) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10730842-B2 Small molecule inhibitors of DYRK1A and uses thereof DYRK1A, DYRK2, DYRK1B MAPT 219/4885GAA 2319/4885KDM4E 1699/4885
US-20190055212-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM6B, KDM5B MAPT 2989/4885GAA 1000/4885KDM4E 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.